Search results for "OLED"

showing 10 items of 349 documents

Metastatic site location may influence the diagnostic accuracy of plasma EGFR-mutation testing in NSCLC: A pooled analysis

2017

Oncologymedicine.medical_specialtyPooled analysisOncologySite locationEgfr mutationbusiness.industryInternal medicinemedicineDiagnostic accuracyHematologybusinessAnnals of Oncology
researchProduct

Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplem…

2017

To the Editor, In their recent article, Stopeck et al. [1] concluded that denosumab confirms its known safety profile even after longterm exposure, or after switching to it from zoledronic acid, and that osteonecrosis of jaws (ONJ) rates increased with increasing exposure to antiresorptives, consistent with previous reports. This is based on the open label extension phase of two phase 3 studies in patients with breast and prostate cancer with bone metastases who were randomized to receive denosumab or zoledronic acid (ZA) [2, 3]. The patients were offered open-label denosumab for up to an additional 2 years after the results of the primary analysis, favorable for denosumab on several aspect…

Oncologymedicine.medical_specialtyPopulationlaw.invention03 medical and health sciencesProstate cancer0302 clinical medicineBreast cancerRandomized controlled triallawInternal medicineNeoplasmsmedicineHumanseducationLetter to the Editoreducation.field_of_studyBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industryOsteonecrosisCancer030206 dentistrymedicine.diseaseSurgeryDenosumabZoledronic acidOncology030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawDenosumabOncology osteonecrosis denosumab metastatic cancer patientsbusinessJaw Diseasesmedicine.drug
researchProduct

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

2016

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, health insurance costs nearly double in the presence of SRE. Zoledronic acid and denosumab are both approved drugs for the prevention or delay of SRE in castration-resistant prostate cancer (CRPC) patients with osseous metastases. However, long-term treatment with one of these two drugs is associated with the development of medication-related osteonecrosis of the jaw (MRONJ). Routine inspections of th…

Oncologymedicine.medical_specialtyReview03 medical and health sciencesProstate cancerzoledronic acid0302 clinical medicineInternal medicinemedicineStage (cooking)General DentistryPathologicalmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)osteonecrosisdenosumab030206 dentistrymedicine.diseaseprostate cancerSurgerylcsh:RK1-715Zoledronic acidDenosumabBone scintigraphy030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry Journal
researchProduct

51P Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)

2021

Oncologymedicine.medical_specialtySafety profilePooled analysisOncologybusiness.industryInternal medicinemedicineIn patientHematologybusinessIntrahepatic CholangiocarcinomaAnnals of Oncology
researchProduct

391MO Impact of diabetes and metformin use on recurrence and outcome in early colon cancer (CC) patients: A pooled analysis of 3 adjuvant trials

2021

Oncologymedicine.medical_specialtybusiness.industryColorectal cancerHematologymedicine.diseaseOutcome (game theory)Adjuvant TrialsMetforminPooled analysisOncologyInternal medicineDiabetes mellitusmedicinebusinessmedicine.drugAnnals of Oncology
researchProduct

Long-Term Outcomes with Ibrutinib Versus the Prior Regimen: A Pooled Analysis in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) with up to 7.5 …

2019

Introduction In MCL, progression-free survival (PFS) generally declines with each successive line of chemoimmunotherapy (CIT). We have previously published that with ibrutinib, a first-in-class oral inhibitor of Bruton's tyrosine kinase and a standard of care treatment (tx) for R/R MCL, median PFS exceeded 2 years (yrs) when used at first relapse (Rule S, et al. Haematologica. 2018;104:e211-e214). Here we present an updated pooled analysis with 15 months (mos) of additional follow-up, and for the first time, a comparison of outcomes with ibrutinib versus the prior regimen. Methods Patients (pts) enrolled in SPARK (MCL2001; NCT01599949), RAY (MCL3001; NCT01646021), and PCYC-1104 (NCT01236391…

Oncologymedicine.medical_specialtybusiness.industryImmunologyCell BiologyHematologymedicine.diseaseBiochemistryCytokine release syndromechemistry.chemical_compoundRegimenPooled analysischemistryInternal medicineIbrutinibRelapsed refractoryLong term outcomesmedicineVindesineMantle cell lymphomabusinessmedicine.drugBlood
researchProduct

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on La…

2018

The recent randomized trial, published by Raje et al., on Lancet Oncology is potentially practice changing. It proposes that denosumab is a valid alternative to zoledronic acid in the treatment of myeloma patients. However, several points need further data and more details, such as information on incidence, diagnosis, and follow-up of osteonecrosis of the jaw (ONJ) cases, observed among treated patients. Adopted definition to adjudicate ONJ cases, type of registration of potential ONJ cases, length of observation are possible causes of potential underestimation of ONJ incidence in their study. Future updated evaluations with longer follow-up, and including actuarial estimation, are required…

Oncologyosteonecrosimedicine.medical_specialtyONJMRONJ; ONJ; denosumab; jaw; medication-related osteonecrosis of the jaw; multiple myeloma; osteonecrosis; osteonecrosis of the jaw; zoledronic acidMRONJlaw.invention03 medical and health scienceszoledronic acid0302 clinical medicinejawRandomized controlled triallawInternal medicinemedicinemedication-related osteonecrosis of the jawGeneral DentistryMultiple myelomabusiness.industryIncidence (epidemiology)Commentosteonecrosisdenosumab030206 dentistrymedicine.diseaselcsh:RK1-715multiple myelomaosteonecrosis of the jawDenosumabZoledronic acid030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry journal
researchProduct

Multiphysics Optimization for First Wall Design Enhancement in Water-Cooled Breeding Blankets

2021

Abstract The commercial feasibility of the first fusion power plant generation adopting D-T plasma is strongly dependent upon the self-sustainability in terms of tritium fuelling. Within such a kind of reactor, the component selected to house the tritium breeding reactions is the breeding blanket, which is further assigned to heat power removal and radiation shielding functions. As a consequence of both its role and position, the breeding blanket is heavily exposed to both surface and volumetric heat loads and, hence, its design requires a typical multiphysics approach, from the neutronics to the thermo-mechanics. During last years, a great deal of effort has been put in the optimization of…

OptimizationNuclear and High Energy PhysicsNeutron transportBreeding blanket Complex method Multiphysics Neutronics Optimization ThermomechanicsComputer scienceMaterials Science (miscellaneous)Water cooledMultiphysicsNuclear engineeringMultiphysicsTK9001-9401Structural integrityMaximizationBlanketFusion powerComplex methodThermomechanicsNuclear Energy and EngineeringComponent (UML)NeutronicsNuclear engineering. Atomic powerBreeding blanketSettore ING-IND/19 - Impianti Nucleari
researchProduct

Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental stude…

2017

Background This study aims to evaluate the influence of changes in the teaching contents on medication-related osteonecrosis of the jaw may have on the knowledge and the capacity for practical case resolution about this pathology. Material and methods A cross-sectional descriptive study was conducted through a survey divided into four sections: degree of means of knowledge acquisition, habitual practice and ability to solve clinical cases. The total number of respondents (n = 225) was divided into two groups: Group A (Year 2015-2016) and Group B (Year 2016-2017). The students in Group B received more teaching content on the subject than group A. Results A total of 175 survey responses were …

Oral Medicine and Pathologybusiness.industryResearcheducationContinuing educationDentistryTeaching program030206 dentistryDental education:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseGroup B03 medical and health sciences0302 clinical medicineZoledronic acid030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASMedicinebusinessOsteonecrosis of the jawGeneral Dentistrymedicine.drug
researchProduct

A simple method for measuring OLEDs efficiency

2015

External quantum efficiency (EQE) of organic light emitting diodes (OLEDs) is among the most important parameters for devices assessment and for comparing OLEDs performance. The EQE is the ratio of the total number of photons emitted by the OLED in all directions to the number of electrons injected.

Organic Electronics Organic LEDs (OLEDs) efficiency measurementSettore ING-INF/01 - Elettronica
researchProduct